BeOne Medicines (ONC) Change in Account Payables (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Change in Account Payables data on file, last reported at -$42.2 million in Q1 2026.

• On a quarterly basis, Change in Account Payables fell 33.64% year-over-year to -$42.2 million in Q1 2026; TTM through Mar 2026 was $69.2 million, a 58.64% increase from a year earlier, with the FY2025 full-year figure at $79.8 million, down 34.29% from the prior year.
• Change in Account Payables for Q1 2026 stood at -$42.2 million, down from $87.2 million in the prior quarter.
• Over the last five years, Change in Account Payables for ONC reached as high as $108.0 million in Q4 2024 and fell as low as -$44.1 million in Q2 2024.
• Historically, Change in Account Payables has averaged $10.4 million across 5 years, with a median of -$4.3 million in 2025.
• On a YoY basis, Change in Account Payables climbed as much as 1192.5% in 2024 and fell as far as 337.19% in 2024.
• Year by year, Change in Account Payables stood at -$8.6 million in 2022, then declined by 15.51% to -$9.9 million in 2023, then soared by 1192.5% to $108.0 million in 2024, then fell by 19.22% to $87.2 million in 2025, then sank by 148.37% to -$42.2 million in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were -$42.2 million in Q1 2026, $87.2 million in Q4 2025, and $28.5 million in Q3 2025.